# Study MIPAE - Melatonin and Essential Arterial Hypertension

> **NCT05257291** · PHASE2 · UNKNOWN · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 23 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT05257291
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-02
- **Primary completion:** 2022-07-14
- **Final completion:** 2024-08
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257291, "Study MIPAE - Melatonin and Essential Arterial Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05257291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*